Clinical trial
Resynchronization Therapy in Normal QRS (RethinQ) Clinical Investigation
NCT00132977 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resynchronization Therapy in Normal QRS (RethinQ) Clinical Investigation
- Lead sponsor
- Abbott Medical Devices
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- July 31, 2007
- Enrollment
- 250 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.